Japan Drug Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Japan Drug Delivery Devices Companies and the market is segmented by route of administration (injectable, topical, ocular, and others), application, and by end user.

Japan Drug Delivery Devices Market Size

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
View Global Report
Market Snapshot1
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2019 - 2022
CAGR 4.50 %

Major Players

Japan Drug Delivery Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Japan Drug Delivery Devices Market Analysis

The Japan Drug Delivery Devices Market is expected to register a CAGR of nearly 4.5% during the forecast period. The major factors driving the Japan Drug Delivery Devices Market are the rising prevalence of chronic diseases and technological advancements.

Drug delivery devices help in delivering the drugs which are beneficial for the targeted population to recover faster. In addition, a rising number of cancers, respiratory are diabetic patients in Japan will promote the adoption of drug delivery devices and drive the overall market. For instance, according to the estimates of the National Cancer Center - Center for Cancer Control and Information Services, the cancer incidence in 2018 was 1,013,600 in Japan, while the most common types of cancer were colorectum, stomach, lung, breast, and prostate cancer. Thus, owing to the above-mentioned factors is expected to drive market growth over the forecast period.

Japan Drug Delivery Devices Market Trends

This section covers the major market trends shaping the Japan Drug Delivery Devices Market according to our research experts:

By Application Cancer is Estimated to Witness a Healthy Growth Over The Forecast Period

Over the years, cancer incidence and mortality have increased in Japan. For instance, according to the World Health Organization (WHO), 2018 statistics indicate that the deaths due to cancer increased to nearly 409,400, in Japan. The increasing mortality rate has been a concerning factor for the Japanese government over the years. As a result, the government and other organizations are taking initiatives to spread awareness regarding cancer and its treatments which is expected to boost the market. Thus, the rising prevalence of cancer and the presence of better R&D infrastructure in the country is expected to drive market growth in the near future.

japan key trend 1.png

Japan Drug Delivery Devices Industry Overview

The Japan Drug Delivery Devices Market is fragmented competitive and consists of several major players. Some of the companies which are currently dominating the market are Mylan N.V., ANTARES PHARMA, INC., Tasei Kako Co. Ltd., GlaxoSmithKline Plc, Novartis AG, Bayer AG, Becton, Dickinson and Company, Johnson & Johnson and 3M Company.

Japan Drug Delivery Devices Market Leaders

  1. Mylan N.V.

  2. ANTARES PHARMA, INC.

  3. Tasei Kako Co. Ltd.

  4. GlaxoSmithKline Plc

  5. Novartis AG

*Disclaimer: Major Players sorted in no particular order

Japan landscape.png
Need More Details on Market Players and Competitors?
Download PDF

Japan Drug Delivery Devices Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Chronic Diseases
    • 4.2.2 Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 Risk of Needlestick Injuries
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 By Route of Administration
    • 5.1.1 Injectable
    • 5.1.2 Topical
    • 5.1.3 Ocular
    • 5.1.4 Other Route of Administration
  • 5.2 By Application
    • 5.2.1 Cancer
    • 5.2.2 Cardiovascular
    • 5.2.3 Diabetes
    • 5.2.4 Infectious diseases
    • 5.2.5 Other Applications
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Surgical Centers
    • 5.3.3 Other End Users

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Mylan N.V.
    • 6.1.2 Antares Pharma, Inc.
    • 6.1.3 Tasei Kako Co. Ltd.
    • 6.1.4 GlaxoSmithKline Plc
    • 6.1.5 Novartis AG
    • 6.1.6 Bayer AG
    • 6.1.7 Becton, Dickinson and Company
    • 6.1.8 Johnson & Johnson
    • 6.1.9 3M Company
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

** Subject To Availablity
**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Japan Drug Delivery Devices Industry Segmentation

As per the scope, drug delivery devices or system are the tools which are used to deliver the drug through the specific route of administration. It enables the introduction of therapeutic substances in the body. The Japan Drug Delivery Devices Market is segmented by route of administration, application and end user.

By Route of Administration Injectable
Topical
Ocular
Other Route of Administration
By Application Cancer
Cardiovascular
Diabetes
Infectious diseases
Other Applications
By End User Hospitals
Ambulatory Surgical Centers
Other End Users
Need A Different Region Or Segment?
Customize Now

Japan Drug Delivery Devices Market Research FAQs

The Japan Drug Delivery Devices Market is projected to register a CAGR of 4.5% during the forecast period (2024-2029)

Mylan N.V., ANTARES PHARMA, INC., Tasei Kako Co. Ltd., GlaxoSmithKline Plc and Novartis AG are the major companies operating in the Japan Drug Delivery Devices Market.

The report covers the Japan Drug Delivery Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Japan Drug Delivery Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

Japan Connected Drug Delivery Devices Industry Report

Statistics for the 2023 Japan Connected Drug Delivery Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Japan Connected Drug Delivery Devices analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

Japan Drug Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)